Diary - News
All news BioMeca and Synthelis sign a commercial agreement
 |
 |
As of February 12, 2018, Synthelis and BioMeca combine their know-how and thus capitalize on their respective technology in developing a joint offer, responding to the needs of their customers.
This joint offering is based on the production of difficult-to-express proteins and the validation of their proper folding by Atomic Force Microscopy (AFM). Thus, this offer combines the cutting-edge expertise of two recognized players in their respective domain: Synthelis, for its cell-free patented technology and BioMeca, for its expertise in the field of mechanical measurement on biological materials.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree